TITLE:
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

CONDITION:
Glaucoma, Angle-Closure

INTERVENTION:
Travoprost (0.004%)

SUMMARY:

      To demonstrate that the intraocular pressure(IOP)-lowering efficacy of Travoprost (0.004%)
      is equal or better than that of Latanoprost 0.005% in patients with chronic angle-closure
      glaucoma.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Adult patients of any race and either sex with chronic angle-closure glaucoma.
      
